ADIPOQ and gestational diabetes: Decreased expression of adiponectin during pregnancy is postulated to augment insulin resistance in skeletal muscle, leading to decreased glucose uptake, pancreatic beta cell dysfunction, hyperglycemia and the development of GDM (Figure 5) [53].